Search | Virtual Health Library

1.

Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study.

Gordon, Max J; Feng, Lei; Strati, Paolo; Lee, Hun Ju; Hagemeister, Fredrick B; Westin, Jason R; Samaniego, Felipe; Marques-Piubelli, Mario L; Vega Vazquez, Francisco; Parra Cuentas, Edwin R; Solis-Soto, Luisa M; Ma, Wencai; Wang, Jing; Claret, Linda; Averill, Barbara; Ibanez, Karina; Fayad, Luis E; Flowers, Christopher R; Green, Michael R; Davis, R Eric; Neelapu, Sattva S; Fowler, Nathan H; Nastoupil, Loretta J.

Cancer ; 130(6): 876-885, 2024 03 15.

Article in English | MEDLINE | ID: mdl-37985359

2.

Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma.

Ma, Man Chun John; Tadros, Saber; Bouska, Alyssa; Heavican, Tayla; Yang, Haopeng; Deng, Qing; Moore, Dalia; Akhter, Ariz; Hartert, Keenan; Jain, Neeraj; Showell, Jordan; Ghosh, Sreejoyee; Street, Lesley; Davidson, Marta; Carey, Christopher; Tobin, Joshua; Perumal, Deepak; Vose, Julie M; Lunning, Matthew A; Sohani, Aliyah R; Chen, Benjamin J; Buckley, Shannon; Nastoupil, Loretta J; Davis, R Eric; Westin, Jason R; Fowler, Nathan H; Parekh, Samir; Gandhi, Maher; Neelapu, Sattva; Stewart, Douglas; Bhalla, Kapil; Iqbal, Javeed; Greiner, Timothy; Rodig, Scott J; Mansoor, Adnan; Green, Michael R.

Haematologica ; 107(3): 690-701, 2022 03 01.

Article in English | MEDLINE | ID: mdl-33792219

3.

Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma.

Zhuang, Junling; Shirazi, Fazal; Singh, Ram Kumar; Kuiatse, Isere; Wang, Hua; Lee, Hans C; Berkova, Zuzana; Berger, Allison; Hyer, Marc; Chattopadhyay, Nibedita; Syed, Sakeena; Shi, Judy Qiuju; Yu, Jie; Shinde, Vaishali; Tirrell, Stephen; Jones, Richard Julian; Wang, Zhiqiang; Davis, R Eric; Orlowski, Robert Z.

Blood ; 133(14): 1572-1584, 2019 04 04.

Article in English | MEDLINE | ID: mdl-30737236

4.

Ibrutinib inhibits pre-BCR⁺ B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK.

Kim, Ekaterina; Hurtz, Christian; Koehrer, Stefan; Wang, Zhiqiang; Balasubramanian, Sriram; Chang, Betty Y; Müschen, Markus; Davis, R Eric; Burger, Jan A.

Blood ; 129(9): 1155-1165, 2017 03 02.

Article in English | MEDLINE | ID: mdl-28031181

5.

Tonic B-cell receptor signaling in diffuse large B-cell lymphoma.

Havranek, Ondrej; Xu, Jingda; Köhrer, Stefan; Wang, Zhiqiang; Becker, Lisa; Comer, Justin M; Henderson, Jared; Ma, Wencai; Man Chun Ma, John; Westin, Jason R; Ghosh, Dipanjan; Shinners, Nicholas; Sun, Luhong; Yi, Allen F; Karri, Anusha R; Burger, Jan A; Zal, Tomasz; Davis, R Eric.

Blood ; 130(8): 995-1006, 2017 08 24.

Article in English | MEDLINE | ID: mdl-28646116

6.

Killing 2 birds with 1 stone in DLBCL.

Davis, R Eric.

Blood ; 138(10): 822-824, 2021 09 09.

Article in English | MEDLINE | ID: mdl-34499154

7.

Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemia.

Piya, Sujan; Kornblau, Steven M; Ruvolo, Vivian R; Mu, Hong; Ruvolo, Peter P; McQueen, Teresa; Davis, R Eric; Hail, Numsen; Kantarjian, Hagop; Andreeff, Michael; Borthakur, Gautam.

Blood ; 128(9): 1260-9, 2016 09 01.

Article in English | MEDLINE | ID: mdl-27268264

8.

Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells.

Ruvolo, Peter P; Ruvolo, Vivian R; Benton, Christopher B; AlRawi, Ahmed; Burks, Jared K; Schober, Wendy; Rolke, James; Tidmarsh, George; Hail, Numsen; Davis, R Eric; Andreeff, Michael.

Biochim Biophys Acta ; 1863(4): 562-71, 2016 Apr.

Article in English | MEDLINE | ID: mdl-26704388

9.

Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy.

Cho, Byung-Sik; Zeng, Zhihong; Mu, Hong; Wang, Zhiqiang; Konoplev, Sergej; McQueen, Teresa; Protopopova, Marina; Cortes, Jorge; Marszalek, Joseph R; Peng, Sheng-Bin; Ma, Wencai; Davis, R Eric; Thornton, Donald E; Andreeff, Michael; Konopleva, Marina.

Blood ; 126(2): 222-32, 2015 Jul 09.

Article in English | MEDLINE | ID: mdl-26031918

10.

Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs.

Mathur, Rohit; Sehgal, Lalit; Havranek, Ondrej; Köhrer, Stefan; Khashab, Tamer; Jain, Neeraj; Burger, Jan A; Neelapu, Sattva S; Davis, R Eric; Samaniego, Felipe.

Haematologica ; 102(2): 373-380, 2017 02.

Article in English | MEDLINE | ID: mdl-27742770

11.

Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance.

Jacamo, Rodrigo; Chen, Ye; Wang, Zhiqiang; Ma, Wencai; Zhang, Min; Spaeth, Erika L; Wang, Ying; Battula, Venkata L; Mak, Po Yee; Schallmoser, Katharina; Ruvolo, Peter; Schober, Wendy D; Shpall, Elizabeth J; Nguyen, Martin H; Strunk, Dirk; Bueso-Ramos, Carlos E; Konoplev, Sergej; Davis, R Eric; Konopleva, Marina; Andreeff, Michael.

Blood ; 123(17): 2691-702, 2014 Apr 24.

Article in English | MEDLINE | ID: mdl-24599548

12.

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.

Davis, R Eric; Ngo, Vu N; Lenz, Georg; Tolar, Pavel; Young, Ryan M; Romesser, Paul B; Kohlhammer, Holger; Lamy, Laurence; Zhao, Hong; Yang, Yandan; Xu, Weihong; Shaffer, Arthur L; Wright, George; Xiao, Wenming; Powell, John; Jiang, Jian-Kang; Thomas, Craig J; Rosenwald, Andreas; Ott, German; Muller-Hermelink, Hans Konrad; Gascoyne, Randy D; Connors, Joseph M; Johnson, Nathalie A; Rimsza, Lisa M; Campo, Elias; Jaffe, Elaine S; Wilson, Wyndham H; Delabie, Jan; Smeland, Erlend B; Fisher, Richard I; Braziel, Rita M; Tubbs, Raymond R; Cook, J R; Weisenburger, Dennis D; Chan, Wing C; Pierce, Susan K; Staudt, Louis M.

Nature ; 463(7277): 88-92, 2010 Jan 07.

Article in English | MEDLINE | ID: mdl-20054396

13.

HSP110 and MYD88: blame the chaperone.

Davis, R Eric.

Blood ; 132(5): 462-463, 2018 08 02.

Article in English | MEDLINE | ID: mdl-30072412

14.

Prognostic impact and targeting of CRM1 in acute myeloid leukemia.

Kojima, Kensuke; Kornblau, Steven M; Ruvolo, Vivian; Dilip, Archana; Duvvuri, Seshagiri; Davis, R Eric; Zhang, Min; Wang, Zhiqiang; Coombes, Kevin R; Zhang, Nianxiang; Qiu, Yi Hua; Burks, Jared K; Kantarjian, Hagop; Shacham, Sharon; Kauffman, Michael; Andreeff, Michael.

Blood ; 121(20): 4166-74, 2013 May 16.

Article in English | MEDLINE | ID: mdl-23564911

15.

Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment.

Rawal, Seema; Chu, Fuliang; Zhang, Min; Park, Hyun Jun; Nattamai, Durga; Kannan, Shibichakravarthy; Sharma, Rakesh; Delgado, David; Chou, Tina; Lin, Heather Y; Baladandayuthapani, Veerabhadran; Luong, Amber; Vega, Francisco; Fowler, Nathan; Dong, Chen; Davis, R Eric; Neelapu, Sattva S.

J Immunol ; 190(12): 6681-93, 2013 Jun 15.

Article in English | MEDLINE | ID: mdl-23686488

16.

Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.

Annunziata, Christina M; Davis, R Eric; Demchenko, Yulia; Bellamy, William; Gabrea, Ana; Zhan, Fenghuang; Lenz, Georg; Hanamura, Ichiro; Wright, George; Xiao, Wenming; Dave, Sandeep; Hurt, Elaine M; Tan, Bruce; Zhao, Hong; Stephens, Owen; Santra, Madhumita; Williams, David R; Dang, Lenny; Barlogie, Bart; Shaughnessy, John D; Kuehl, W Michael; Staudt, Louis M.

Cancer Cell ; 12(2): 115-30, 2007 Aug.

Article in English | MEDLINE | ID: mdl-17692804

17.

Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival.

Bidère, Nicolas; Ngo, Vu N; Lee, Jeansun; Collins, Cailin; Zheng, Lixin; Wan, Fengyi; Davis, R Eric; Lenz, Georg; Anderson, D Eric; Arnoult, Damien; Vazquez, Aimé; Sakai, Keiko; Zhang, Jun; Meng, Zhaojing; Veenstra, Timothy D; Staudt, Louis M; Lenardo, Michael J.

Nature ; 458(7234): 92-6, 2009 Mar 05.

Article in English | MEDLINE | ID: mdl-19118383

18.

Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial.

Westin, Jason R; Chu, Fuliang; Zhang, Min; Fayad, Luis E; Kwak, Larry W; Fowler, Nathan; Romaguera, Jorge; Hagemeister, Fredrick; Fanale, Michelle; Samaniego, Felipe; Feng, Lei; Baladandayuthapani, Veerabhadran; Wang, Zhiqiang; Ma, Wencai; Gao, Yanli; Wallace, Michael; Vence, Luis M; Radvanyi, Laszlo; Muzzafar, Tariq; Rotem-Yehudar, Rinat; Davis, R Eric; Neelapu, Sattva S.

Lancet Oncol ; 15(1): 69-77, 2014 Jan.

Article in English | MEDLINE | ID: mdl-24332512

19.

Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial.

Fowler, Nathan H; Davis, R Eric; Rawal, Seema; Nastoupil, Loretta; Hagemeister, Fredrick B; McLaughlin, Peter; Kwak, Larry W; Romaguera, Jorge E; Fanale, Michelle A; Fayad, Luis E; Westin, Jason R; Shah, Jatin; Orlowski, Robert Z; Wang, Michael; Turturro, Francesco; Oki, Yasuhiro; Claret, Linda C; Feng, Lei; Baladandayuthapani, Veerabhadran; Muzzafar, Tariq; Tsai, Kenneth Y; Samaniego, Felipe; Neelapu, Sattva S.

Lancet Oncol ; 15(12): 1311-8, 2014 Nov.

Article in English | MEDLINE | ID: mdl-25439689

20.

Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma.

Voo, Kui Shin; Foglietta, Myriam; Percivalle, Elena; Chu, Fuliang; Nattamai, Durga; Harline, Megan; Lee, Seung-Tae; Bover, Laura; Lin, Heather Y; Baladandayuthapani, Veerabhadran; Delgado, David; Luong, Amber; Davis, R Eric; Kwak, Larry W; Liu, Yong-Jun; Neelapu, Sattva S.

Int J Cancer ; 135(12): 2834-46, 2014 Dec 15.

Article in English | MEDLINE | ID: mdl-24771328

Virtual Health Library

Hypertension

Your selection (0)

Export format:

Export: